Zhenhao Liu
Overview
Explore the profile of Zhenhao Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Yang C, Liu Z, Dai P, Zhang Y, Huang P, Lin Y, et al.
Sheng Wu Gong Cheng Xue Bao
. 2022 Jul;
38(6):2201-2212.
PMID: 35786472
The prediction of tumor drug sensitivity plays an important role in clinically guiding patients' medication. In this paper, a multi-omics data-based cancer drug sensitivity prediction model was constructed by Stacking...
22.
Zhang H, Li H, Tan M, Liu Z, Gu J, Zhang Y, et al.
Ann Transl Med
. 2022 Jun;
10(10):575.
PMID: 35722378
Background: At present, the diagnosis of tuberculosis (TB) is still challenging, and improving the efficiency of diagnosis can help prevent and control TB. This retrospective clinical study aimed to assess...
23.
Liu Z, Zhang S, Ouyang J, Wu D, Chen L, Zhou W, et al.
Dis Markers
. 2022 May;
2022:4971621.
PMID: 35634447
The heterogeneity of tumor microenvironment (TME) of hepatocellular carcinoma (HCC) may relate to cell-cell interaction event (CCE) dysregulation and would affect therapeutic responses and clinical outcomes. To reveal the differentiation...
24.
Liu C, Zhang Y, Jian X, Tan X, Lu M, Ouyang J, et al.
Genes (Basel)
. 2022 May;
13(5).
PMID: 35627168
A proteogenomics-based neoantigen prediction pipeline, namely ProGeo-neo, was previously developed by our team to predict neoantigens, allowing the identification of class-I major histocompatibility complex (MHC) binding peptides based on single-nucleotide...
25.
Lu M, Xu L, Jian X, Tan X, Zhao J, Liu Z, et al.
Front Immunol
. 2022 May;
13:855976.
PMID: 35493528
Neoantigens are widely reported to induce T-cell response and lead to tumor regression, indicating a promising potential to immunotherapy. Previously, we constructed an open-access database, i.e., dbPepNeo, providing a systematic...
26.
Ouyang J, Qin G, Liu Z, Jian X, Shi T, Xie L
iScience
. 2022 Apr;
25(5):104190.
PMID: 35479398
Patients with cancer with different molecular characterization and subtypes result in different response to anticancer therapeutics and survival. To identify features that are associated with prognosis is essential to precision...
27.
Liu Z, Zhang S, Li H, Guo J, Wu D, Zhou W, et al.
Front Genet
. 2022 Apr;
13:844604.
PMID: 35401705
Cell-cell interaction event (CCEs) dysregulation may relate to the heterogeneity of the tumor microenvironment (TME) and would affect therapeutic responses and clinical outcomes. To reveal the alteration of the immune...
28.
Feng X, Guo J, An G, Wu Y, Liu Z, Meng B, et al.
Adv Sci (Weinh)
. 2022 Jan;
9(9):e2104491.
PMID: 35088582
It has been previously shown that (never in mitosis gene A)-related kinase 2 (NEK2) is upregulated in multiple myeloma (MM) and contributes to drug resistance. However, the mechanisms behind this...
29.
Xu L, Jian X, Liu Z, Zhao J, Zhang S, Lin Y, et al.
Front Genet
. 2021 Oct;
12:741226.
PMID: 34646307
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy with high morbidity and mortality worldwide. Tumor immune microenvironment (TIME) plays a pivotal role in the outcome and treatment of...
30.
Liu H, Liu J, Liu Z, Wang Q, Liu J, Feng D, et al.
J Agric Food Chem
. 2021 Aug;
69(35):10114-10120.
PMID: 34428895
Our previous study showed that lycopene reduced the absorption of cholesterol in Caco-2 cells through inhibiting Niemann-Pick C1-Like 1 (NPC1L1) expression. Herein, we aimed to explore whether lycopene supplementation can...